circadian rhythm comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-05. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small molecule; not a steroid or peptide. |
| Primary targets | NR1D1 and NR1D2 | Also known as REV-ERBα and REV-ERBβ. |
| Studied routes | Intraperitoneal in rodents | Oral bioavailability in humans is not established. |
| Human approval | No approved therapeutic indication | No recognized clinical use. |
| Key uncertainty | Human physiological effects | Preclinical findings may not translate. |
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
=== Dogs === Paracetamol has been reported to be as effective as aspirin in the treatment of musculoskeletal pain in dogs. Paracetamol is considered a weak analgesic and is usually combined with codeine, although the efficacy of this formulation has not been evaluated. The main effect of toxicity in dogs is liver damage, and GI ulceration has been reported. Acetylcysteine treatment is efficacious in dogs when administered within two hours of paracetamol ingestion.
==== Interfaith efforts ==== Curiosity about Islam increased after the attacks. As a result, many mosques and Islamic centers began holding open houses and participating in outreach efforts to educate non-Muslims about the faith. In the first 10 years after the attacks, interfaith community service increased from 8 to 20 percent, and the percentage of U.S. congregations involved in interfaith worship doubled from 7 to 14 percent.
Triple-decker complexes are composed of three Cp anions and two metal cations in alternating order. The first triple-decker sandwich complex, [Ni2Cp3]+, was reported in 1972. Many examples have been reported subsequently, often with boron-containing rings.
Sources: en.wikipedia.org
His only other appearance came in Game 6, when he pitched a scoreless fourth and fifth inning's in Pittsburgh's 12–0 defeat. Despite posting a 15.43 ERA, Mizell became a World Series champion for the only time in his career, as the Pirates clinched the series in Game 7 on Bill Mazeroski's game-ending home run. Entering the 1961 season, Sports Illustrated predicted that Mizell "may win more this year." Indeed, he got off to a 4–1 start, posting a 3.57 ERA through May 24. However, Mizell slumped in 1961. He lost seven straight decisions through the end of July, getting moved to the bullpen and only making two starts between June 15 and July 27. Used as a starter during the week of August 6–12, however, he won two games, the second of which was a five-hit shutout of the Phillies. It would be his only shutout of the year. Mizell started two more games that month but lost both and was used only twice in September, as a relief pitcher. In 25 games (17 starts), he had a 7–10 record, a 5.04 ERA, 37 strikeouts, and 31 walks in 100 innings pitched. Mizell was slightly late for spring training due to the birth of his second son in 1962. In his first start of the year, he defeated the expansion New York Mets, limiting them to one unearned run over seven innings. That was his only win through May 7, as he posted a 4.96 ERA in three games (three starts). On May 7, he was traded to the Mets for Jim Marshall, much to the chagrin of Pirates fans and players, with whom Mizell had been popular.
Southern blotting A molecular biology method used to detect a specific sequence in DNA samples. The method combines separation of DNA fragments by gel electrophoresis, transfer of the DNA to a synthetic membrane, and subsequent identification of target fragments with radio-labeled or fluorescent hybridization probes. Compare northern blotting, western blotting, and eastern blotting.
Kennedy left the Foster administration when he was elected Louisiana State Treasurer in 1999, having unseated incumbent Ken Duncan with 55.6% of the vote, or 621,796 votes, to Duncan's 44.4%, or 497,319 votes. Kennedy was reelected treasurer without opposition in 2003, 2007 and 2011. In 2015, he defeated his sole challenger with 80% of the vote.
=== Associated conditions === Sjögren's disease is associated with a number of other medical conditions, many of which are autoimmune or rheumatic disorders, such as celiac disease, fibromyalgia, systemic lupus erythematosus (lupus), autoimmune thyroiditis, multiple sclerosis and spondyloarthropathy, and several malignancies, principally non-Hodgkin lymphoma. Sjogren's is the second most common cause of dysautonomia.
Sources: en.wikipedia.org
==== Seeds ==== Lotus seeds are mostly oval or spherical, with sizes varying according to varieties. They are generally 1.2–1.8 cm long, with diameters ranging from 0.8 to 1.4 cm and a weight of 1.1–1.4 g. After lotus seeds have been decorticated and peeled, they are edible and rich in nutrients and can be dried for storage. Their nutritional values can differ due to culture environments and varieties. Not only do these seeds contain proteins of high quality and are rich in a variety of essential amino acids including high contents of albumin (42%) and globulin (27%), they also contain unsaturated fatty acids, carbohydrates, vitamins, calcium, iron, zinc, phosphorus and other trace elements. They also provide water-soluble polysaccharides, alkaloids, flavonoids, superoxide dismutase, and other bioactive components. Lotus seeds also contain particularly large amounts of vitamins, including VB1, VB2, VB6 and Vitamin E. The functional components (polyphenols, protein, polysaccharides) in N. nucifera seeds can help combat high blood pressure, diabetes, and gallstones. After lotus seed germination, crude protein and fat levels in the endosperm significantly increase. It is therefore an important method to enhance its nutritional quality.
20 April Nixon announced that he would order the withdrawal of 150,000 U.S. troops from South Vietnam over the next 12 months in a gradual policy of Vietnamization, putting more responsibility on the South Vietnamese.
== In humans == There are many legends involving healing wounds by licking them or applying saliva. Saint Magdalena de Pazzi is said to have cured a nun of sores and scabs in 1589 by licking her limbs. The Roman Emperor Vespasian is said to have performed a healing of a blind man using his saliva. Pliny the Elder in his Natural History reported that a fasting woman's saliva is an effective cure for bloodshot eyes. In the Hebrew Bible saliva is associated with uncleanliness; however, in the Gospels there are three incidents where Jesus uses saliva to heal (Mark 7:33, Mark 8:23, John 9:6). Köstenberger suggests "by using saliva to cure a man, Jesus claims to possess unusual spiritual authority." There are potential health hazards in wound licking due to infection risk, especially in immunocompromised patients. Human saliva contains a wide variety of bacteria that are harmless in the mouth, but that may cause significant infection if introduced into a wound. A notable case was a diabetic man who licked his bleeding thumb following a minor bicycle accident, and subsequently had to have the thumb amputated after it became infected with Eikenella corrodens from his saliva.
== Further reading == Aziz, Nusrate; Asadullah, M Niaz (2017). "Military spending, armed conflict and economic growth in developing countries in the post–Cold War era". Journal of Economic Studies. 44 (1): 47–68. Bartel, Fritz (2022). The Triumph of Broken Promises: The End of the Cold War and the Rise of Neoliberalism. Harvard University Press. ISBN 9780674976788. Henriksen, Thomas H. (2017). Cycles in US Foreign Policy Since the Cold War. Palgrave Macmillan. Jones, Bruce D.; Stedman, Stephen John (2017). "Civil Wars & the Post–Cold War International Order". Dædalus. 146 (4): 33–44. Menon, Rajan; Rumer, Eugene B., eds. (2015). Conflict in Ukraine: The Unwinding of the Post–Cold War Order. MIT Press. Peterson, James W. (2017). Russian-American relations in the post–Cold War world. Oxford UP. Sakwa, Richard (2017). Russia against the Rest: The Post–Cold War Crisis of World Order. Cambridge UP. p. 362. Wood, Luke B. (2017). "The politics of identity and security in post–Cold War Western and Central Europe". European Politics and Society. 18 (4): 552–556.
=== Morphological instabilities === In an ideal world, the spatial concentration of particles within the SSZ would remain constant throughout solidification. As it happens, though, the concentration of particles does change during compression, and this process is highly sensitive to solidification speed. At low freezing rates, Brownian motion takes place, allowing particles to move easily away from the solid-liquid interface and maintain a homogeneous suspension. In this situation, the suspension is always warmer than the solidified portion. At fast solidification speeds, approaching VC, the concentration, and concentration gradient at the solid-liquid interface increases because particles cannot redistribute soon enough. When it has built up enough, the freezing point of the suspension is below the temperature gradient in the solution and morphological instabilities can occur. For situations where the particle concentration bleeds into the diffusion layer, both the actual and freezing temperature dip below the equilibrium freezing temperature creating an unstable system. Often, these situations lead to the formation of what are known as ice lenses. These morphological instabilities can trap particles, preventing full redistribution and resulting in inhomogeneous distribution of solids along the freezing direction as well as discontinuities in the ceramic walls, creating voids larger than intrinsic pores within the walls of the porous ceramic.
Sources: en.wikipedia.org
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.
REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.
Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.